Extrahepatic Delivery

How this supports a project

Extrahepatic delivery is not one material class: the specification must name the target cell or tissue, biological barriers, payload, administration route, formulation strategy, controls, and model.

Start with the target cell and model

LNP composition can alter protein adsorption, cellular uptake, organ distribution, and functional cargo delivery. Ionizable lipid, helper lipid, sterol, PEG-lipid, supplemental lipids, and surface ligands may all affect the result, but no component provides a universal extrahepatic rule.

Published screening studies also show that nanoparticle delivery and cellular responses can differ across cell types, administration routes, and species. A formulation identified in one mouse model should therefore be treated as evidence for that model, not as proof of human tissue delivery.

Typical material-planning workflow

Define the delivery problem

State the target cell and tissue, extracellular and intracellular barriers, payload, administration route, and functional endpoint.

Choose a strategy to test

Separate composition-driven targeting, ligand-mediated targeting, local administration, and other delivery hypotheses instead of combining them under one label.

Build a controlled material set

Vary defined lipid identities, ratios, supplemental components, ligand-lipid conjugates, or spacers while keeping appropriate variables fixed.

Formulate matched controls

Include the base LNP, untargeted or inactive-ligand controls, empty-particle controls, and cargo controls needed to interpret delivery.

Measure particle quality

Confirm size, dispersity, encapsulation, composition, surface ligand where relevant, RNA integrity, and stability before biological comparison.

Measure functional delivery in the relevant model

Distinguish biodistribution or uptake from cytosolic delivery and cargo function, then examine off-target tissues and model dependence.

What to define before an inquiry

Target definition

Name the cell population and tissue compartment, not only an organ.

Payload and route

Specify mRNA, siRNA, guide RNA, or other cargo together with administration route and intended functional readout.

Base formulation

Provide all lipid identities, ratios, cargo-to-lipid basis, mixing method, and buffer conditions.

Targeting variable

Define the ligand, supplemental lipid, helper-lipid change, or other variable and the rationale for testing it.

Comparison and translation plan

State matched controls, cell-level functional assays, off-target measurements, and how species or model differences will be handled.

Application boundary

This page organizes materials for extrahepatic-delivery research. It does not claim delivery to a named organ or cell type, provide a validated formulation, or establish biodistribution, efficacy, safety, clinical translation, or regulatory status.

Related catalog and technical pages

LNP and delivery lipidsBrowse ionizable lipid analogs, PEG lipids, helper phospholipids, sterols, and functional delivery-lipid tools.Lipid materials for deliveryReview lipid classes, anchor and chain variables, and ligand-lipid conjugates used in delivery research.Targeted LNP delivery materialsReview how a targeting hypothesis is translated into ligand, anchor, spacer, formulation, and control definitions.Ionizable lipid designReview headgroup, linker, tail, ionization, and formulation variables used to compare ionizable lipids.PEG-lipid selectionReview PEG chain, anchor, incorporation level, and particle-property questions.